Further experiments reveal the regulatory mechanism of NR2F1‐AS1/miR‐363/ABCC1 pathway on HCC oxaliplatin resistance, suggesting the vital role of NR2F1‐AS1 in HCC research and providing the novel therapeutic target. The gene discussed is NR2F1; the disease is hepatocellular carcinoma.